Manning Raymond, MD

The California Neuropsychopharmacology Clinical Research Institute (CNRI) operates in Los Angeles and San Diego, specializing in Phase I-IV clinical drug trials. With facilities designed for both inpatient and outpatient studies, CNRI focuses on a range of clinical trial indications including schizophrenia, bipolar disorder, major depressive disorder, PTSD, ADHD, Alzheimer's, and various sleep disorders. CNRI is recognized internationally for its commitment to advancing clinical research and improving patient outcomes. The institute also conducts studies involving healthy volunteers, pharmacokinetic research, and cardiac studies, ensuring a comprehensive approach to clinical investigation. Generated from the website